RenBio had the pleasure of attending the Keystone Symposia on “Next Generation Antibody Therapeutics: From Discovery to Patient” last month, where our Director of Research, Marek Drozdz, Ph.D., presented a poster showcasing the potential of RenBio’s MYO Technology to deliver antibodies and therapeutic proteins in a way that is durable and efficacious. The poster presentation by Dr. Drozdz was met with great interest and enthusiasm by the attendees, and the event was a tremendous success.
Recalling the event, he noted “Discussing the cutting-edge science behind MYO Technology with fellow researchers is always exciting, and this meeting did not disappoint.”
RenBio was thrilled to have the opportunity to meet and network with so many talented researchers and scientists coming from different backgrounds and areas of expertise. The symposia provided an excellent platform for sharing ideas and learning about the latest advances in antibody therapeutics.
Overall, RenBio had a fantastic experience at the conference. We thoroughly enjoyed meeting and interacting with fellow researchers and scientists and look forward to attending future events! The mountainous views in the area were absolutely beautiful during the conference, adding to the already delightful experience of the event.
